High expression of miR-181c as a predictive marker of recurrence in stage II colorectal cancer

INTRODUCTION: A standard treatment for stage II colorectal cancer (CRC) is surgical resection without adjuvant chemotherapy. However, the recurrence rate of these patients is approximately 20%. To date, there are no robust biomarkers suitable for predicting recurrence in stage II CRC patients. In th...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamazaki, Nobuyoshi, Koga, Yoshikatsu, Taniguchi, Hirokazu, Kojima, Motohiro, Kanemitsu, Yukihide, Saito, Norio, Matsumura, Yasuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351683/
https://www.ncbi.nlm.nih.gov/pubmed/28036302
http://dx.doi.org/10.18632/oncotarget.14344

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351683/
https://www.ncbi.nlm.nih.gov/pubmed/28036302
http://dx.doi.org/10.18632/oncotarget.14344

Ejemplares similares